• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国的黑色素瘤预后:确定改善护理的障碍。

Melanoma prognosis in the United States: Identifying barriers for improved care.

机构信息

Department of Internal Medicine, University of Utah, Salt Lake City, Utah.

College of Medicine, Texas A&M University, Temple, Texas.

出版信息

J Am Acad Dermatol. 2019 May;80(5):1256-1262. doi: 10.1016/j.jaad.2019.01.003. Epub 2019 Jan 17.

DOI:10.1016/j.jaad.2019.01.003
PMID:30659870
Abstract

BACKGROUND

Despite improvements in melanoma mortality, disparities in melanoma survival persist. We evaluated possible sociodemographic and health care-based predictors of differences in melanoma survival in the United States by using the melanoma mortality-to-incidence ratio (MIR).

METHODS

State-based MIRs were calculated by using US cancer statistics data from 1999 to 2014. Pearson correlations and linear regressions were used to determine associations between MIR and dermatologist density, primary care provider density, number of physicians by state, number of National Cancer Institute-designated cancer centers, health care spending per capita, average household income, racial/ethnic makeup of the population, percentage of uninsured individuals, and percentage with a bachelor's degree.

RESULTS

The mean overall MIR was 0.15 ± 0.04; only Alaska was an outlier (0.24). No state MIRs increased significantly over time; MIR decreased for most states. Multivariable analysis revealed that states with more active physicians (P = .02) and a higher percentage non-Hispanic whites (P = .004) had higher MIRs (poorer survival). Significant Pearson correlations were seen between MIR and melanoma incidence (r = -0.72, P < .001), melanoma mortality (r = 0.38, P < .001), dermatologist density (r = 0.32, P < .001), and National Cancer Institute-designated cancer center count (r = -0.12, P = .001).

CONCLUSIONS

Melanoma survival is improved in higher-incidence areas and areas with higher dermatologist density. These findings highlight areas of poorer melanoma survival and the need for local studies evaluating disparities in melanoma survival.

摘要

背景

尽管黑色素瘤死亡率有所提高,但黑色素瘤存活率仍存在差异。我们通过使用黑色素瘤死亡率与发病率比(MIR)来评估美国黑色素瘤存活率差异的可能社会人口统计学和医疗保健预测因素。

方法

根据 1999 年至 2014 年的美国癌症统计数据,计算了基于州的 MIR。使用皮尔逊相关和线性回归来确定 MIR 与皮肤科医生密度、初级保健提供者密度、州内医生人数、国立癌症研究所指定癌症中心数量、人均医疗保健支出、平均家庭收入、人口种族/族裔构成、未参保人数百分比和拥有学士学位的百分比之间的关联。

结果

总体平均 MIR 为 0.15±0.04;只有阿拉斯加是个例外(0.24)。没有州的 MIR 随时间显著增加;大多数州的 MIR 下降。多变量分析显示,医生活动更活跃的州(P=0.02)和非西班牙裔白人比例较高的州(P=0.004)的 MIR 更高(生存率更差)。MIR 与黑色素瘤发病率(r=-0.72,P<0.001)、黑色素瘤死亡率(r=0.38,P<0.001)、皮肤科医生密度(r=0.32,P<0.001)和国立癌症研究所指定癌症中心数量(r=-0.12,P=0.001)之间存在显著的皮尔逊相关。

结论

黑色素瘤发病率较高的地区和皮肤科医生密度较高的地区,黑色素瘤生存率得到改善。这些发现突出了黑色素瘤生存率较差的地区,并需要进行当地研究,以评估黑色素瘤生存率的差异。

相似文献

1
Melanoma prognosis in the United States: Identifying barriers for improved care.美国的黑色素瘤预后:确定改善护理的障碍。
J Am Acad Dermatol. 2019 May;80(5):1256-1262. doi: 10.1016/j.jaad.2019.01.003. Epub 2019 Jan 17.
2
The association of physician-specialty density and melanoma prognosis in the United States, 1988 to 1993.1988年至1993年美国内科医生专业密度与黑色素瘤预后的关联
J Am Acad Dermatol. 2009 Jan;60(1):51-8. doi: 10.1016/j.jaad.2008.08.040. Epub 2008 Oct 19.
3
Melanoma prognosis in Europe: far from equal.欧洲的黑色素瘤预后:差距悬殊。
Br J Dermatol. 2014 Jul;171(1):179-82. doi: 10.1111/bjd.12923. Epub 2014 Jun 24.
4
Association of increased dermatologist density with lower melanoma mortality.皮肤科医生密度增加与黑色素瘤死亡率降低之间的关联。
Arch Dermatol. 2012 Feb;148(2):174-8. doi: 10.1001/archdermatol.2011.345.
5
Is Access to Care Associated With Stage at Presentation and Survival for Melanoma Patients?黑色素瘤患者获得医疗服务的机会与就诊时的分期及生存率相关吗?
J Cutan Med Surg. 2019 Nov/Dec;23(6):586-594. doi: 10.1177/1203475419870177. Epub 2019 Aug 28.
6
Adolescent and young adult oncology patients: Disparities in access to specialized cancer centers.青少年及青年肿瘤患者:在获得专业癌症中心治疗机会方面的差异。
Cancer. 2017 Jul 1;123(13):2516-2523. doi: 10.1002/cncr.30562. Epub 2017 Feb 27.
7
Access to medical care, dental care, and prescription drugs: the roles of race/ethnicity, health insurance, and income.获得医疗保健、牙科护理和处方药:种族/族裔、医疗保险和收入的作用。
South Med J. 2010 Jun;103(6):509-16. doi: 10.1097/SMJ.0b013e3181d9c2d8.
8
Racial disparities in melanoma survival.黑色素瘤存活率的种族差异。
J Am Acad Dermatol. 2016 Nov;75(5):983-991. doi: 10.1016/j.jaad.2016.06.006. Epub 2016 Jul 28.
9
Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States.美国 18 至 64 岁成年人黑色素瘤患者的医疗保险与结局的相关性。
J Am Acad Dermatol. 2016 Feb;74(2):309-16. doi: 10.1016/j.jaad.2015.09.054. Epub 2015 Dec 6.
10
Population-based geographic access to parent and satellite National Cancer Institute Cancer Center Facilities.基于人群的获取父母和卫星国家癌症研究所癌症中心设施的地理位置。
Cancer. 2017 Sep 1;123(17):3305-3311. doi: 10.1002/cncr.30727. Epub 2017 May 2.

引用本文的文献

1
Oregon primary care providers as a frontline defense in the War on Melanoma™: improving access to melanoma education.俄勒冈州的初级保健提供者在“黑色素瘤之战™”中作为一线防御力量:改善黑色素瘤教育的可及性。
Front Med (Lausanne). 2025 Mar 14;12:1427136. doi: 10.3389/fmed.2025.1427136. eCollection 2025.
2
The intersection of melanoma survival and social determinants of health in the United States: A systematic review.美国黑色素瘤生存率与健康的社会决定因素的交叉研究:一项系统综述。
JAAD Int. 2024 Aug 2;17:126-138. doi: 10.1016/j.jdin.2024.07.006. eCollection 2024 Dec.
3
Persistent poverty and incidence-based melanoma mortality in Texas.
德克萨斯州持续存在的贫困与基于发病率的黑色素瘤死亡率。
Cancer Causes Control. 2024 Jun;35(6):973-979. doi: 10.1007/s10552-023-01841-5. Epub 2024 Feb 29.
4
Geographic disparities in access to immunotherapy clinical trials for metastatic melanoma.转移性黑色素瘤免疫治疗临床试验可及性的地域差异。
Arch Dermatol Res. 2023 May;315(4):1033-1036. doi: 10.1007/s00403-022-02433-0. Epub 2022 Oct 28.
5
Impact of Medicaid Expansion Status and Race on Metastatic Disease at Diagnosis in Patients with Melanoma.医疗补助扩张状况和种族对黑色素瘤患者诊断时转移性疾病的影响。
J Racial Ethn Health Disparities. 2022 Dec;9(6):2291-2299. doi: 10.1007/s40615-021-01166-6. Epub 2021 Oct 14.
6
Incidence and Survival Rates of Cutaneous Melanoma in South Korea Using Nationwide Health Insurance Claims Data.利用全国健康保险索赔数据评估韩国皮肤黑色素瘤的发病率和生存率。
Cancer Res Treat. 2022 Jul;54(3):937-949. doi: 10.4143/crt.2021.871. Epub 2021 Sep 30.
7
Melanoma Extension for Community Healthcare Outcomes: A Feasibility Study of Melanoma Screening Implementation in Primary Care Settings.黑色素瘤社区医疗结果拓展:基层医疗环境中黑色素瘤筛查实施的可行性研究
Cureus. 2021 May 29;13(5):e15322. doi: 10.7759/cureus.15322.
8
Pandemic Pressure: Teledermatology and Health Care Disparities.大流行压力:远程皮肤病学与医疗保健差距
J Patient Exp. 2021 Feb 23;8:2374373521996982. doi: 10.1177/2374373521996982. eCollection 2021.
9
Aloin promotes cell apoptosis by targeting HMGB1-TLR4-ERK axis in human melanoma cells.芦荟素通过靶向人黑素瘤细胞中的HMGB1-TLR4-ERK轴促进细胞凋亡。
EXCLI J. 2020 May 14;19:641-651. eCollection 2020.
10
Low accuracy of self-reported family history of melanoma in high-risk patients.高危患者自我报告的黑色素瘤家族史准确性较低。
Fam Cancer. 2021 Jan;20(1):41-48. doi: 10.1007/s10689-020-00187-0.